Our team Voronoi Health Analytics Inc. recognizes #ColorectalCancerAwareness month. Our AI-driven imaging solutions help researchers uncover key biomarkers, driving innovation in prevention and treatment. Our software will inference the bowel in blue💙

There’s never been a better way to visualize data in DAFS—now with advanced 3D & volumetric rendering for an extraordinary data visualization experience. DAFS unlocks virtually limitless research insights, putting anatomical data at your fingertips. Highlights: - Enhanced

We are proud that our AI-driven body composition analysis software contributed to a recent study in Japan, investigating the prognostic impact of adipose tissue loss after gastric cancer surgery. This highlights the global impact of our technology in advancing medical research.

We're proud to have presented at the National PET Imaging Platform (NPIP) earlier today – NPIP is the UK's first-of-its-kind national total-body PET imaging platform for driving forward world-leading drug discovery research. Voronoi Health Analytics Inc.'s DAFS Platform is uniquely

One year ago, a landmark study from Kaiser Permanente Research NorCal was published in JAMA Surgery, leveraging DAFS Server scaled across their data center to analyze preoperative 3D abdominal CT scans from over 48,000 patients. The findings demonstrated that automated measures of muscle quantity and

A new study in npj Breast Cancer reveals that body composition metrics can predict toxicity and response to trastuzumab deruxtecan in metastatic breast cancer patients. This research underscores the importance of personalized treatment strategies based on body composition and how

Researchers at City of Hope published a new study demonstrating strong correlations between CT, ultrasound, and bioelectrical impedance muscle measurements in HCT patients. We're proud to support their work with our Data Analysis Facilitation Suite Platform to perform automated

A new randomized phase II trial in Journal of Clinical Oncology assessed adding tocilizumab to gemcitabine/nab-paclitaxel for advanced pancreatic cancer. We're proud to have supported the researchers with DAFS for CT-based body composition analysis. Incredible work and insights from University of Copenhagen Research

DAFS Server 1.6.0 is now live. This on-prem, AI-driven platform powered body composition analysis of over 48,000 3D CT scans at Kaiser Permanente Research NorCal using Docker container orchestration. 1.6.0 delivers even better performance for large research endeavors. ℹ️ Reach out to us at

At #ASN2025, Amanda Bode, MC, RDN, CSO, LDN of Cleveland Clinic showcases how CT imaging and our DAFS AI software can be used to quantify the impact of nutrition interventions in pancreatic cancer patients. Her poster at D47 provides evidence supporting the safety and efficacy